Self-rated health among pregnant women: Associations with objective health indicators, psychological functioning, and serum inflammatory markers

Annals of Behavioral Medicine

Volumn 46, Issue 3, 2013, Pages 295-309

  Christian, Lisa M ^a,b   Iams, Jay ^a   Porter, Kyle ^b   Leblebicioglu, Binnaz ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cytokines; Inflammation; Pregnancy; Pregnant women; Self rated health; Subjective health

Indexed keywords

AUTACOID; BIOLOGICAL MARKER;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; BLOOD; FEMALE; HEALTH; HEALTH BEHAVIOR; HEALTH STATUS INDICATOR; HUMAN; MENTAL STRESS; PREGNANCY; PREGNANT WOMAN; PSYCHOLOGICAL ASPECT; SELF REPORT;

ADAPTATION, PSYCHOLOGICAL; ADULT; BIOLOGICAL MARKERS; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATION MEDIATORS; ORAL HEALTH; PREGNANCY; PREGNANT WOMEN; SELF REPORT; STRESS, PSYCHOLOGICAL;

EID: 84888204368     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-013-9521-7     Document Type: Article

References (102)

1. Dasbach EJ, Klein R, Klein BEK, Moss SE. Self-rated health and mortality in people with diabetes. Am J Public Health. 1994;84:1775-1779.
2. Bosworth HB, Siegler IC, Brummett BH, et al. The association between self-rated health and mortality in a well-characterized sample of coronary artery disease patients. Med Care. 1999;37:1226-1236.
3. Thong MSY, Kaptein AA, Benyamini Y, et al. Association between a self-rated health question and mortality in young and old dialysis patients: A cohort study. Am J Kidney Dis. 2008;52:111-117.
4. Idler EL, Benyamini Y. Self-rated health and mortality: A review of twenty-seven community studies. J Health Soc Behav. 1997;38:21-37.
5. Benyamini Y, Idler EL. Community studies reporting association between self-rated health and mortality - additional studies, 1995 to 1998. Res Aging. 1999;21:392-401.
6. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab. 2003;88:2019-2025.
7. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
8. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med. 2003;115:429-435.
9. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JVB, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003;115:278-283.
10. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: A magnificent pathway. J Gerontol Ser A Biol Sci Med Sci. 2006;61:575-584.
11. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-160.
12. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997;52:M201-M208.
13. Lekander M, Elofsson S, Neve I-M, Hansson L-O, Unden A-L. Self-rated health is related to levels of circulating cytokines. Psychosom Med. 2004;66:559-563.
14. Unden AL, Andreasson A, Elofsson S, et al. Inflammatory cytokines, behaviour and age as determinants of self-rated health in women. Clin Sci (Lond). 2007;112:363-373.
15. Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun. 2005;19:555-563.
16. Dowd JB, Zajacova A. Does self-rated health mean the same thing across socioeconomic groups? Evidence from biomarker data. Ann Epidemiol. 2010;20:743-749.
17. Christian LM, Glaser R, Porter K, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK. Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology. 2011;36:1495-1504.
18. Tanno K, Ohsawa M, Onoda T, et al. Poor self-rated health is significantly associated with elevated C-reactive protein levels in women, but not in men, in the Japanese general population. J Psychosom Res. 2012;73:225-231.
19. Andreasson AN, Szulkin R, Unden AL, von Essen J, Nilsson LG, Lekander M. Inflammation and positive affect are associated with subjective health in women of the general population. J Health Psychol. 2012;18(3);331-320.
20. Dizon-Townson DS. Preterm labour and delivery: A genetic predisposition. Paediatr Perinat Epidemiol. 2001;15:57-62.
21. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin-6 in pre-term labor: Association with infection. J Clin Invest. 1990;85:1392-1400.
22. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1993;169:805-816.
23. Romero R, Yoon BH, Mazor M, Gomez R, Gonzales R, Diamond MP. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 1993;169:839-851.
24. Murtha AP, Sinclair T, Hauser ER, Swamy GK, Herbert WN, Heine RP. Maternal serum cytokines in preterm premature rupture of membranes. Obstet Gynecol. 2007;109:121-127.
25. Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. Br J Obstet Gynaecol. 2005;112:16-18.
26. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Sem Fetal Neonatal Med. 2006;11:317-326.
27. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91:914-920.
28. Boggess KA, Urlaub DM, Moos MK, Polinkovsky M, El-Khorazaty J, Lorenz C. Knowledge and beliefs regarding oral health among pregnant women. J Am Dent Assoc. 2011;142:1275-1282.
29. Bates SB, Riedy CA. Changing knowledge and beliefs through an oral health pregnancy message. J Public Health Dent. 2012;72:104-111.
30. Anderson C, Harris MS, Kovarik R, Skelton J. Discovering expectant mothers' beliefs about oral health: An application of the Centering Pregnancy Smiles program. Int Q Community Health Educ. 2009;30:115-140.
31. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol. 2002;7:79-89.
32. Ware JE, Sherbourne CD. The MOS 36-Item-Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
33. Lobel M. The Revised Prenatal Life Events Scale (PLES). Stony Brook: Stony Brook University; 1996.
34. Lobel M, Cannella DL, Graham JE, DeVincent C, Schneider J, Meyer BA. Pregnancy-specific stress, prenatal health behaviors, and birth outcomes. Health Psychol. 2008;27:604-615.
35. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
36. Christian LM, Franco A, Glaser R, Iams J. Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun. 2009;23:750-754.
37. Christian LM, Franco A, Iams JD, Sheridan J, Glaser R. Depressive symptoms predict exaggerated inflammatory response to in vivo immune challenge during human pregnancy. Brain Behav Immun. 2010;24:49-53.
38. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: A prospective cohort study. Hum Reprod. 2009;24:146-153.
39. Phillips GS, Wise LA, Rich-Edwards JW, Stampfer MJ, Rosenberg L. Prepregnancy depressive symptoms and preterm birth in the Black Women's Health Study. Ann Epidemiol. 2010;20:8-15.
40. Orr ST, James SA, Blackmore Prince C. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol. 2002;156:797-802.
41. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.
42. Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, Porto M, Sandman CA. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med. 1996;58:432-446.
43. Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol. 1999;180:S257-S263.
44. Spielberger CD. State-Trait Anxiety Inventory: A Comprehensive Bibliography. 2nd ed. Palo Alto: Consulting Psychologists Press; 1989.
45. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31(Pt 3):301-306.
46. Meades R, Ayers S. Anxiety measures validated in perinatal populations: A systematic review. J Affect Disord. 2011;133:1-15.
47. Lobel M. The Revised Prenatal Distress Questionnaire (NUPDQ). Stony Brook: State University of New York; 1996.
48. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
49. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 2003;100:9090-9095.
50. Glaser R, Robles T, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses following influenza vaccination in older adults. Arch Gen Psychiatry. 2003;60:1009-1014.
51. Han B. Depressive symptoms and self-rated health in community-dwelling older adults: A longitudinal study. J Am Geriatr Soc. 2002;50:1549-1556.
52. Mulsant BH, Ganguli M, Seaberg EC. The relationship between self-rated health and depressive symptoms in an epidemiological sample of community-dwelling older adults. J Am Geriatr Soc. 1997;45:954-958.
53. Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM. Risk factors for depressive symptoms during pregnancy: A systematic review (vol 202, pg 5, 2010). Am J Obstet Gynecol. 2011;205:236-236.
54. Hale L, Hill TD, Burdette AM. Does sleep quality mediate the association between neighborhood disorder and self-rated physical health? Prev Med. 2010;51:275-278.
55. Magee CA, Caputi P, Iverson DC. Relationships between self-rated health, quality of life and sleep duration in middle aged and elderly Australians. Sleep Med. 2011;12:346-350.
56. Geiger SD, Sabanayagam C, Shankar A. The relationship between insufficient sleep and self-rated health in a nationally representative sample. J Environ Public Health. 2012;2012:518263.
57. Shankar A, Charumathi S, Kalidindi S. Sleep duration and self-rated health: The National Health Interview Survey 2008. Sleep. 2011;34:1173-1177.
58. Jain S, Bower J, Irwin MR. Psychoneuroimmunology of fatigue and sleep disturbance: The role of pro-inflammatory cytokines. In: Segerstrom SC, ed. The Oxford Handbook of Psychoneuroimmunology. Oxford: Oxford University Press; 2012:321-340.
59. Okun ML, Hall M, Coussons-Read ME. Sleep disturbances increase interleukin-6 production during pregnancy: Implications for pregnancy complications. Reprod Sci. 2007;14:560-567.
60. Okun ML, Coussons-Read ME. Sleep disruption during pregnancy: How does it influence serum cytokines? J Reprod Immunol. 2007;73:158-165.
61. Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Preterm Birth: Causes, Consequences, and Prevention. Washington, D.C: National Academies Press; 2007.
62. Monga M. Maternal cardiovascular, respiratory, and renal adaptation to pregnancy. In: Creasy RRRK, Iams JD, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 6th ed. Philadelphia: Saunders Elsevier; 2009.
63. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain Behav Immun. 2007;21:901-912.
64. Weatherall M. Prevention of falls and fall-related fractures in community-dwelling older adults: A meta-analysis of estimates of effectiveness based on recent guidelines. Intern Med J. 2004;34:102-108.
65. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation. 2012;125:188-197.
66. Janz NK, Becker MH. The health belief model: A decade later. Health Educ Q. 1984;11:1-47.
67. Borrell LN, Crawford ND. Social disparities in periodontitis among United States adults 1999-2004. Community Dent Oral Epidemiol. 2008;36:383-391.
68. Khader YS, Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: A meta-analysis. J Periodontol. 2005;76:161-165.
69. Offenbacher S, Beck JD, Jared HL, et al. Effects of periodontal therapy on rate of preterm delivery: A randomized controlled trial. Obstet Gynecol. 2009;114:551-559.
70. Michalowicz BS, Hodges JS, DiAngelis AJ, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006;355:1885-1894.
71. Macones GA, Parry S, Nelson DB, et al. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: Results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol. 2010;202:e1-e8.
72. Newnham JP, Newnham IA, Ball CM, et al. Treatment of periodontal disease during pregnancy: A randomized controlled trial. Obstet Gynecol. 2009;114:1239-1248.
73. Chambrone L, Pannuti CM, Guglielmetti MR, Chambrone LA. Evidence grade associating periodontitis with preterm birth and/or low birth weight: II: A systematic review of randomized trials evaluating the effects of periodontal treatment. J Clin Periodontol. 2011;38:902-914.
74. Kim AJ, Lo AJ, Pullin DA, Thornton-Johnson DS, Karimbux NY. Scaling and root planning treatment for periodontitis to reduce preterm birth and low birth weight: A systematic review and meta-analysis of randomized controlled trials. J Periodontol. 2012;83:1508-1519.
75. Polyzos NP, Polyzos IP, Mauri D, et al. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: A metaanalysis of randomized trials. Am J Obstet Gynecol. 2009;200:225-232.
76. Xiong X, Buekens P, Goldenberg RL, Offenbacher S, Qian X. Optimal timing of periodontal disease treatment for prevention of adverse pregnancy outcomes: Before or during pregnancy? Am J Obstet Gynecol. 2011;205:111.e1-111.e6.
77. James NM, Smouse PE, Carroll BJ, Haines RF. Affective illness and HLA frequencies: No compelling association. Neuropsychobiology. 1980;6:208-216.
78. Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med. 2005;67:679-687.
79. Dye BA, Vargas CM, Lee JJ, Magder L, Tinanoff N. Assessing the relationship between children's oral health status and that of their mothers. J Am Dent Assoc. 2011;142:173-183.
80. Centers for Disease Control: National Oral Health Surveillance System: Dental Visits. Accessed February 12, 2013 from http://apps.nccd.cdc.gov/nohss.
81. Racial/ethnic disparities in self-rated health status among adults with and without disabilities - United States, 2004-2006. MMWR Morb Mortal Wkly Rep. 2008, 57:1069-1073.
82. Farmer MM, Ferraro KF. Are racial disparities in health conditional on socioeconomic status? Soc Sci Med. 2005;60:191-204.
83. Ostrove JM, Adler NE, Kuppermann M, Washington AE. Objective and subjective assessments of socioeconomic status and their relationship to self-rated health in an ethnically diverse sample of pregnant women. Health Psychol. 2000;19:613-618.
84. Frieden TR et al. CDC Health Disparities and Inequalities Report - United States, 2011. MMWR Surveill Summ. 2011;60(Suppl):1-2.
85. Manderbacka K, Kareholt I, Martikainen P, Lundberg O. The effect of point of reference on the association between self-rated health and mortality. Soc Sci Med. 2003;56:1447-1452.
86. Flaster H, Bernhagen J, Calandra T, Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: Regulation of inflammation and immunity. Mol Endocrinol. 2007;21:1267-1280.
87. Calandra T, Bucala R. Macrophage migration inhibitory factor: A counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm. 1995;47:39-51.
88. Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor - an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum. 2003;48:291-299.
89. Burger-Kentischer A, Gobel H, Kleemann R, et al. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis. 2006;184:28-38.
90. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol. 2003;170:1274-1282.
91. Pearce BD. The role of a unique immunohormonal molecule (MIF) in depression during pregnancy. NARSAD's 16th Annual Scientific Symposium. New York City: 2004.
92. Todros T, Bontempo S, Piccoli E, et al. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;123:162-166.
93. Pearce BD, Garvin SE, Grove J, et al. Serum macrophage migration inhibitory factor in the prediction of preterm delivery. Am J Obstet Gynecol. 2008;199(46):e41-e46.
94. Yilmaz Ö, Küçük M, Kebapçilar L, et al. Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus. Gynecol Endocrinol. 2012;28:76-79.
95. Haas JS, Jackson RA, Fuentes-Afflick E, et al. Changes in the health status of women during and after pregnancy. J Gen Intern Med. 2005;20:45-51.
96. Curry AE, Vogel I, Skogstrand K, et al. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J Reprod Immunol. 2008;77:152-160.
97. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediat Inflamm. 1998;7:69-72.
98. Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal-pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994;57:149-155.
99. Opsjon SL, Wathen NC, Tingulstad S, et al. Tumor-necrosis-factor, interleukin-1, and interleukin-6 in normal human-pregnancy. Am J Obstet Gynecol. 1993;169:397-404.
100. Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod. 2000;15:2011-2017.
101. Szarka A, Rigo J Jr, Lazar L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
102. Molvarec A, Szarka A, Walentin S, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol. 2011;9:124.